Our data showed that, unlike other adult cancer murine models such as melanoma or colorectal cancer,11 anti-PD1 therapy was ineffective against neuroblastoma tumors with induced MMR deficiency. Here, PDCD1 is linked to mismatch repair cancer syndrome 1.